NDC 69097-262
TOPOTECAN HYDROCHLORIDE
Topotecan Hydrochloride
TOPOTECAN HYDROCHLORIDE is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Cipla Usa Inc.. The primary component is Topotecan Hydrochloride.
| Product ID | 69097-262_4e757b90-6761-4586-914f-6bc194402399 |
| NDC | 69097-262 |
| Product Type | Human Prescription Drug |
| Proprietary Name | TOPOTECAN HYDROCHLORIDE |
| Generic Name | Topotecan Hydrochloride |
| Dosage Form | Injection, Powder, Lyophilized, For Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2010-12-01 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA091199 |
| Labeler Name | Cipla USA Inc. |
| Substance Name | TOPOTECAN HYDROCHLORIDE |
| Active Ingredient Strength | 4 mg/4mL |
| Pharm Classes | Topoisomerase Inhibitor [EPC],Topoisomerase Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |